These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6689383)

  • 1. A functional assay for protein C in human plasma.
    Francis RB; Patch MJ
    Thromb Res; 1983 Dec; 32(6):605-13. PubMed ID: 6689383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simplified PTT-based protein C activity assay using the thrombin-thrombomodulin complex.
    Francis RB
    Thromb Res; 1986 Feb; 41(3):337-44. PubMed ID: 3010489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behaviour of protein C inhibitor in intravascular coagulation and liver disease.
    Francis RB; Thomas W
    Thromb Haemost; 1984 Aug; 52(1):71-4. PubMed ID: 6548588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency states.
    Rapaport SI; Zivelin A; Donnelly K
    Am J Clin Pathol; 1987 Apr; 87(4):491-7. PubMed ID: 3826014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast functional protein C assay using Protac, a novel protein C activator.
    Martinoli JL; Stocker K
    Thromb Res; 1986 Aug; 43(3):253-64. PubMed ID: 3526629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and under oral anticoagulant therapy.
    Takahashi H; Tatewaki W; Wada K; Shibata A
    Clin Chim Acta; 1989 Jun; 182(2):195-208. PubMed ID: 2528431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of protein C and protein S in disease states.
    Esmon NL; D'Angelo A; Vigano-D'Angelo S; Esmon CT; Comp PC
    Dev Biol Stand; 1987; 67():75-82. PubMed ID: 2956141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.
    Vigano D'Angelo S; Comp PC; Esmon CT; D'Angelo A
    J Clin Invest; 1986 Feb; 77(2):416-25. PubMed ID: 3511097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
    Abildgaard U; Larsen ML
    Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory determination of heparin cofactor II.
    Ezenagu LC; Brandt JT
    Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation.
    Conlan MG; Tomasini BR; Schultz RL; Mosher DF
    Blood; 1988 Jul; 72(1):185-90. PubMed ID: 2455567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation.
    Griffin JH; Mosher DF; Zimmerman TS; Kleiss AJ
    Blood; 1982 Jul; 60(1):261-4. PubMed ID: 6896290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
    Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
    Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
    España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
    Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL; Bick MD; Fekete LF
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
    Katsuura Y; Aoki K; Tanabe H; Kiyoki M; Funatsu A
    Thromb Res; 1994 Nov; 76(4):353-62. PubMed ID: 7871494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits.
    Tazawa S; Ichikawa K; Misawa K; Fukuyama J; Hamano S; Miyata H; Sakuragawa N
    Thromb Res; 1995 Dec; 80(5):391-8. PubMed ID: 8588200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
    Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.